Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 28 entries
Sorted by: Best Match Show Resources per page
Antibody Therapeutics in Oncology.

Immunotherapy (Los Angeles, Calif.)

Wold ED, Smider VV, Felding BH.
PMID: 27081677
Immunotherapy (Los Angel). 2016 Mar;2(1). Epub 2016 Feb 01.

One of the newer classes of targeted cancer therapeutics is monoclonal antibodies. Monoclonal antibody therapeutics are a successful and rapidly expanding drug class due to their high specificity, activity, favourable pharmacokinetics, and standardized manufacturing processes. Antibodies are capable of...

Cite
Wold ED, Smider VV, Felding BH. Antibody Therapeutics in Oncology. Immunotherapy (Los Angel). 2016;2(1)
Wold, E. D., Smider, V. V., & Felding, B. H. (2016). Antibody Therapeutics in Oncology. Immunotherapy (Los Angeles, Calif.), 2(1), .
Wold, Erik D, et al. "Antibody Therapeutics in Oncology." Immunotherapy (Los Angeles, Calif.) vol. 2,1 (2016).
Wold ED, Smider VV, Felding BH. Antibody Therapeutics in Oncology. Immunotherapy (Los Angel). 2016 Mar;2(1). Epub 2016 Feb 01. PMID: 27081677; PMCID: PMC4829403.
Copy Download .nbib Format: NLM
From Polyclonal Sera to Recombinant Antibodies: A Review of Immunological Detection of Gluten in Foodstuff.

Foods (Basel, Switzerland)

Garcia-Calvo E, García-García A, Madrid R, Martin R, García T.
PMID: 33396828
Foods. 2020 Dec 30;10(1). doi: 10.3390/foods10010066.

Gluten is the ethanol-soluble protein fraction of cereal endosperms like wheat, rye, and barley. It is widely used in the food industry because of the physical-chemical properties it gives to dough. Nevertheless, there are some gluten-related diseases that are...

Cite
Garcia-Calvo E, García-García A, Madrid R, et al. From Polyclonal Sera to Recombinant Antibodies: A Review of Immunological Detection of Gluten in Foodstuff. Foods. 2020;10(1)doi: 10.3390/foods10010066.
Garcia-Calvo, E., García-García, A., Madrid, R., Martin, R., & García, T. (2020). From Polyclonal Sera to Recombinant Antibodies: A Review of Immunological Detection of Gluten in Foodstuff. Foods (Basel, Switzerland), 10(1), . https://doi.org/10.3390/foods10010066
Garcia-Calvo, Eduardo, et al. "From Polyclonal Sera to Recombinant Antibodies: A Review of Immunological Detection of Gluten in Foodstuff." Foods (Basel, Switzerland) vol. 10,1 (2020). doi: https://doi.org/10.3390/foods10010066
Garcia-Calvo E, García-García A, Madrid R, Martin R, García T. From Polyclonal Sera to Recombinant Antibodies: A Review of Immunological Detection of Gluten in Foodstuff. Foods. 2020 Dec 30;10(1). doi: 10.3390/foods10010066. PMID: 33396828; PMCID: PMC7824297.
Copy Download .nbib Format: NLM
Identification of Heteroreceptors Complexes and Signal Transduction Events Using Bioluminescence Resonance Energy Transfer (BRET).

Bio-protocol

Reyes-Resina I, Jiménez J, Navarro G, Franco R.
PMID: 33654881
Bio Protoc. 2019 Oct 05;9(19):e3385. doi: 10.21769/BioProtoc.3385. eCollection 2019 Oct 05.

Detecting protein-protein interactions by co-immunoprecipitation provided a major advancement in the immunology research field. In the G-protein-coupled receptors (GPCRs) research field, colocalization and co-immunoprecipitation were used to detect interactions, but doubts arose due to specificity of the antibodies (monoclonal...

Cite
Reyes-Resina I, Jiménez J, Navarro G, et al. Identification of Heteroreceptors Complexes and Signal Transduction Events Using Bioluminescence Resonance Energy Transfer (BRET). Bio Protoc. 2019;9(19):e3385doi: 10.21769/BioProtoc.3385.
Reyes-Resina, I., Jiménez, J., Navarro, G., & Franco, R. (2019). Identification of Heteroreceptors Complexes and Signal Transduction Events Using Bioluminescence Resonance Energy Transfer (BRET). Bio-protocol, 9(19), e3385. https://doi.org/10.21769/BioProtoc.3385
Reyes-Resina, Irene, et al. "Identification of Heteroreceptors Complexes and Signal Transduction Events Using Bioluminescence Resonance Energy Transfer (BRET)." Bio-protocol vol. 9,19 (2019): e3385. doi: https://doi.org/10.21769/BioProtoc.3385
Reyes-Resina I, Jiménez J, Navarro G, Franco R. Identification of Heteroreceptors Complexes and Signal Transduction Events Using Bioluminescence Resonance Energy Transfer (BRET). Bio Protoc. 2019 Oct 05;9(19):e3385. doi: 10.21769/BioProtoc.3385. eCollection 2019 Oct 05. PMID: 33654881; PMCID: PMC7853939.
Copy Download .nbib Format: NLM
Follicular lymphoma - treatment and prognostic factors.

Revista brasileira de hematologia e hemoterapia

Luminari S, Bellei M, Biasoli I, Federico M.
PMID: 23049385
Rev Bras Hematol Hemoter. 2012;34(1):54-9. doi: 10.5581/1516-8484.20120015.

Follicular lymphoma is the second most frequent non-Hodgkin lymphoma accounting for about 10-20% of all lymphomas in western countries. The median age at diagnosis is 60 years old. The clinical presentation is usually characterized by asymptomatic peripheral adenopathy in...

Cite
Luminari S, Bellei M, Biasoli I, et al. Follicular lymphoma - treatment and prognostic factors. Rev Bras Hematol Hemoter. 2012;34(1):54-9doi: 10.5581/1516-8484.20120015.
Luminari, S., Bellei, M., Biasoli, I., & Federico, M. (2012). Follicular lymphoma - treatment and prognostic factors. Revista brasileira de hematologia e hemoterapia, 34(1), 54-9. https://doi.org/10.5581/1516-8484.20120015
Luminari, Stefano, et al. "Follicular lymphoma - treatment and prognostic factors." Revista brasileira de hematologia e hemoterapia vol. 34,1 (2012): 54-9. doi: https://doi.org/10.5581/1516-8484.20120015
Luminari S, Bellei M, Biasoli I, Federico M. Follicular lymphoma - treatment and prognostic factors. Rev Bras Hematol Hemoter. 2012;34(1):54-9. doi: 10.5581/1516-8484.20120015. PMID: 23049385; PMCID: PMC3459616.
Copy Download .nbib Format: NLM
New Trends in Inflammatory Bowel Disease.

GE Portuguese journal of gastroenterology

Palmela C, Torres J, Cravo M.
PMID: 28868386
GE Port J Gastroenterol. 2015 May 11;22(3):103-111. doi: 10.1016/j.jpge.2015.03.009. eCollection 2015.

Inflammatory bowel disease (IBD) is a chronic idiopathic inflammatory disease of the gastrointestinal (GI) tract. In the past decade a shift in the treatment paradigm of IBD has ensued. The availability of drugs capable of inducing mucosal healing, combined...

Cite
Palmela C, Torres J, Cravo M. New Trends in Inflammatory Bowel Disease. GE Port J Gastroenterol. 2015;22(3):103-111doi: 10.1016/j.jpge.2015.03.009.
Palmela, C., Torres, J., & Cravo, M. (2015). New Trends in Inflammatory Bowel Disease. GE Portuguese journal of gastroenterology, 22(3), 103-111. https://doi.org/10.1016/j.jpge.2015.03.009
Palmela, Carolina, et al. "New Trends in Inflammatory Bowel Disease." GE Portuguese journal of gastroenterology vol. 22,3 (2015): 103-111. doi: https://doi.org/10.1016/j.jpge.2015.03.009
Palmela C, Torres J, Cravo M. New Trends in Inflammatory Bowel Disease. GE Port J Gastroenterol. 2015 May 11;22(3):103-111. doi: 10.1016/j.jpge.2015.03.009. eCollection 2015. PMID: 28868386; PMCID: PMC5579988.
Copy Download .nbib Format: NLM
Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study.

Intestinal research

Nakamura S, Imaeda H, Nishikawa H, Iimuro M, Matsuura M, Oka H, Oku J, Miyazaki T, Honda H, Watanabe K, Nakase H, Andoh A.
PMID: 30301337
Intest Res. 2018 Oct;16(4):554-562. doi: 10.5217/ir.2018.00027. Epub 2018 Oct 10.

BACKGROUND/AIMS: Noninvasive objective monitoring is advantageous for optimizing treatment strategies in patients inflammatory bowel disease (IBD). Fecal calprotectin (FCP) is superior to traditional biomarkers in terms of assessing the activity in patients with IBD. However, there are the differences...

Cite
Nakamura S, Imaeda H, Nishikawa H, et al. Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study. Intest Res. 2018;16(4):554-562doi: 10.5217/ir.2018.00027.
Nakamura, S., Imaeda, H., Nishikawa, H., Iimuro, M., Matsuura, M., Oka, H., Oku, J., Miyazaki, T., Honda, H., Watanabe, K., Nakase, H., & Andoh, A. (2018). Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study. Intestinal research, 16(4), 554-562. https://doi.org/10.5217/ir.2018.00027
Nakamura, Shiro, et al. "Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study." Intestinal research vol. 16,4 (2018): 554-562. doi: https://doi.org/10.5217/ir.2018.00027
Nakamura S, Imaeda H, Nishikawa H, Iimuro M, Matsuura M, Oka H, Oku J, Miyazaki T, Honda H, Watanabe K, Nakase H, Andoh A. Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter study. Intest Res. 2018 Oct;16(4):554-562. doi: 10.5217/ir.2018.00027. Epub 2018 Oct 10. PMID: 30301337; PMCID: PMC6223455.
Copy Download .nbib Format: NLM
Application of hypersensitivity skin testing in chemotherapy-induced pneumonitis.

Asia Pacific allergy

Kuo JC, Hawkins CA, Yip D.
PMID: 26539407
Asia Pac Allergy. 2015 Oct;5(4):234-6. doi: 10.5415/apallergy.2015.5.4.234. Epub 2015 Oct 28.

Skin testing has been utilised to determine the culprit allergenic agent in drug reactions. Its application in the setting of hypersensitivity reaction relating to combination chemotherapeutic regimens may help identify the causative drug, allowing drug that is safe to...

Cite
Kuo JC, Hawkins CA, Yip D. Application of hypersensitivity skin testing in chemotherapy-induced pneumonitis. Asia Pac Allergy. 2015;5(4):234-6doi: 10.5415/apallergy.2015.5.4.234.
Kuo, J. C., Hawkins, C. A., & Yip, D. (2015). Application of hypersensitivity skin testing in chemotherapy-induced pneumonitis. Asia Pacific allergy, 5(4), 234-6. https://doi.org/10.5415/apallergy.2015.5.4.234
Kuo, James C, et al. "Application of hypersensitivity skin testing in chemotherapy-induced pneumonitis." Asia Pacific allergy vol. 5,4 (2015): 234-6. doi: https://doi.org/10.5415/apallergy.2015.5.4.234
Kuo JC, Hawkins CA, Yip D. Application of hypersensitivity skin testing in chemotherapy-induced pneumonitis. Asia Pac Allergy. 2015 Oct;5(4):234-6. doi: 10.5415/apallergy.2015.5.4.234. Epub 2015 Oct 28. PMID: 26539407; PMCID: PMC4630463.
Copy Download .nbib Format: NLM
Profiling of primary peripheral blood- and monocyte-derived dendritic cells using monoclonal antibodies from the HLDA10 Workshop in Wollongong, Australia.

Clinical & translational immunology

Autenrieth SE, Grimm S, Rittig SM, Grünebach F, Gouttefangeas C, Bühring HJ.
PMID: 26682057
Clin Transl Immunology. 2015 Nov 13;4(11):e50. doi: 10.1038/cti.2015.29. eCollection 2015 Nov.

Dendritic cells (DCs) arise from hematopoietic stem cells and develop into a discrete cellular lineage distinct from other leucocytes. Mainly three phenotypically and functionally distinct DC subsets are described in the human peripheral blood (PB): plasmacytoid DCs (pDCs), which...

Cite
Autenrieth SE, Grimm S, Rittig SM, et al. Profiling of primary peripheral blood- and monocyte-derived dendritic cells using monoclonal antibodies from the HLDA10 Workshop in Wollongong, Australia. Clin Transl Immunology. 2015;4(11):e50doi: 10.1038/cti.2015.29.
Autenrieth, S. E., Grimm, S., Rittig, S. M., Grünebach, F., Gouttefangeas, C., & Bühring, H. J. (2015). Profiling of primary peripheral blood- and monocyte-derived dendritic cells using monoclonal antibodies from the HLDA10 Workshop in Wollongong, Australia. Clinical & translational immunology, 4(11), e50. https://doi.org/10.1038/cti.2015.29
Autenrieth, Stella E, et al. "Profiling of primary peripheral blood- and monocyte-derived dendritic cells using monoclonal antibodies from the HLDA10 Workshop in Wollongong, Australia." Clinical & translational immunology vol. 4,11 (2015): e50. doi: https://doi.org/10.1038/cti.2015.29
Autenrieth SE, Grimm S, Rittig SM, Grünebach F, Gouttefangeas C, Bühring HJ. Profiling of primary peripheral blood- and monocyte-derived dendritic cells using monoclonal antibodies from the HLDA10 Workshop in Wollongong, Australia. Clin Transl Immunology. 2015 Nov 13;4(11):e50. doi: 10.1038/cti.2015.29. eCollection 2015 Nov. PMID: 26682057; PMCID: PMC4673437.
Copy Download .nbib Format: NLM
Double-bullet radioimmunotargeting therapy in 31 primary liver cancer patients.

World journal of gastroenterology

Wu YD, Zhou DN, Gang YQ, Hu XH, Li ZG, Song XQ, He HP, Yang KZ, Huang BY.
PMID: 27239136
World J Gastroenterol. 1997 Sep 15;3(3):165. doi: 10.3748/wjg.v3.i3.165.

AIM: To observe the effect of double bullet immunotargeting therapy with chemotherapy and internal radiotherapy on primary liver cancer.METHODS: The polyclonal horse antibody against human AFP (anti-AFPAb) and the monoclonal murine antibody against human AFP (anti-AFPMcAb) were used as...

Cite
Wu YD, Zhou DN, Gang YQ, et al. Double-bullet radioimmunotargeting therapy in 31 primary liver cancer patients. World J Gastroenterol. 1997;3(3):165doi: 10.3748/wjg.v3.i3.165.
Wu, Y. D., Zhou, D. N., Gang, Y. Q., Hu, X. H., Li, Z. G., Song, X. Q., He, H. P., Yang, K. Z., & Huang, B. Y. (1997). Double-bullet radioimmunotargeting therapy in 31 primary liver cancer patients. World journal of gastroenterology, 3(3), 165. https://doi.org/10.3748/wjg.v3.i3.165
Wu, Y D, et al. "Double-bullet radioimmunotargeting therapy in 31 primary liver cancer patients." World journal of gastroenterology vol. 3,3 (1997): 165. doi: https://doi.org/10.3748/wjg.v3.i3.165
Wu YD, Zhou DN, Gang YQ, Hu XH, Li ZG, Song XQ, He HP, Yang KZ, Huang BY. Double-bullet radioimmunotargeting therapy in 31 primary liver cancer patients. World J Gastroenterol. 1997 Sep 15;3(3):165. doi: 10.3748/wjg.v3.i3.165. PMID: 27239136; PMCID: PMC4842877.
Copy Download .nbib Format: NLM
Competitive ELISA.

Methods in molecular biology (Clifton, N.J.)

Makarananda K, Neal GE.
PMID: 23150318
Methods Mol Biol. 1992;10:267-72. doi: 10.1385/0-89603-204-3:267.

Enzyme-linked immunosorbent assay (ELISA) is a very useful technique for the specific and sensitive assay of certain compounds, in which suitable antibodies, monoclonal or polyclonal, to the compounds are available. The technique has found particular application in the monitoring...

Cite
Makarananda K, Neal GE. Competitive ELISA. Methods Mol Biol. 1992;10:267-72doi: 10.1385/0-89603-204-3:267.
Makarananda, K., & Neal, G. E. (1992). Competitive ELISA. Methods in molecular biology (Clifton, N.J.), 10267-72. https://doi.org/10.1385/0-89603-204-3:267
Makarananda, K, and Neal, G E. "Competitive ELISA." Methods in molecular biology (Clifton, N.J.) vol. 10 (1992): 267-72. doi: https://doi.org/10.1385/0-89603-204-3:267
Makarananda K, Neal GE. Competitive ELISA. Methods Mol Biol. 1992;10:267-72. doi: 10.1385/0-89603-204-3:267. PMID: 23150318.
Copy Download .nbib Format: NLM
Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin.

Iranian journal of biotechnology

Farahi L, Ghaemimanesh F, Milani S, Razavi SM, Bayat AA, Rabbani H, Akhondi MM.
PMID: 31457049
Iran J Biotechnol. 2019 Jan 11;17(1):e2277. doi: 10.21859/ijb.2277. eCollection 2019 Jan.

BACKGROUND: The unique expression of fibromodulin (FMOD) in patients with chronic lymphocytic leukemia (CLL) has been previously reported. Detecting FMOD in CLL patients using specific anti-FMOD mAbs might provide a promising method in detection, monitoring, and prognosis of CLL.OBJECTIVES:...

Cite
Farahi L, Ghaemimanesh F, Milani S, et al. Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin. Iran J Biotechnol. 2019;17(1):e2277doi: 10.21859/ijb.2277.
Farahi, L., Ghaemimanesh, F., Milani, S., Razavi, S. M., Bayat, A. A., Rabbani, H., & Akhondi, M. M. (2019). Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin. Iranian journal of biotechnology, 17(1), e2277. https://doi.org/10.21859/ijb.2277
Farahi, Lia, et al. "Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin." Iranian journal of biotechnology vol. 17,1 (2019): e2277. doi: https://doi.org/10.21859/ijb.2277
Farahi L, Ghaemimanesh F, Milani S, Razavi SM, Bayat AA, Rabbani H, Akhondi MM. Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin. Iran J Biotechnol. 2019 Jan 11;17(1):e2277. doi: 10.21859/ijb.2277. eCollection 2019 Jan. PMID: 31457049; PMCID: PMC6697857.
Copy Download .nbib Format: NLM
Rapid generation of high-level antibodies in vitro and in vivo.

Discovery medicine

Fang J, Jooss K.
PMID: 20704874
Discov Med. 2005 Aug;5(28):367-70.

Extract: During the past decade, important advances in biotechnology include the invention of an array of technologies that have resulted in the generation of monoclonal antibodies with human sequences. These technologies include humanization of mouse antibodies using molecular techniques,...

Cite
Fang J, Jooss K. Rapid generation of high-level antibodies in vitro and in vivo. Discov Med. 2005;5(28):367-70
Fang, J., & Jooss, K. (2005). Rapid generation of high-level antibodies in vitro and in vivo. Discovery medicine, 5(28), 367-70.
Fang, Jianmin, and Jooss, Karin. "Rapid generation of high-level antibodies in vitro and in vivo." Discovery medicine vol. 5,28 (2005): 367-70.
Fang J, Jooss K. Rapid generation of high-level antibodies in vitro and in vivo. Discov Med. 2005 Aug;5(28):367-70. PMID: 20704874.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 28 entries